-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M6VkVVQ1lork92C3T7+LUdxS1uhrclzAtmZQ79cPQFYjrK8cpn71qst55KACroi3 FkDepWM2QnGPI/Fdj2SS9w== 0001144204-08-032224.txt : 20080527 0001144204-08-032224.hdr.sgml : 20080526 20080527154541 ACCESSION NUMBER: 0001144204-08-032224 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080527 DATE AS OF CHANGE: 20080527 EFFECTIVENESS DATE: 20080527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cheswold Lane Funds CENTRAL INDEX KEY: 0001359318 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-21891 FILM NUMBER: 08860713 BUSINESS ADDRESS: STREET 1: 100 FRONT STREET, SUITE 960 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 610-940-5330 MAIL ADDRESS: STREET 1: 100 FRONT STREET, SUITE 960 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 0001359318 S000012740 Cheswold Lane International High Dividend Fund C000034318 Institutional N-Q 1 v114267_nq.htm Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM N-Q
 
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT
INVESTMENT COMPANY
 
 
Investment Company Act File Number 811-21891
 
Cheswold Lane Funds
(Exact name of registrant as specified in charter)
 
100 Front Street, Suite 960
West Conshohocken, PA 19428
(Address of principal executive offices) (Zip code)
 
 
Colleen Quinn Scharpf
Cheswold Lane Asset Management, LLC
100 Front Street, Suite 960
West Conshohocken, PA 19428
(Name and address of agent for service)
 
Registrant's telephone number, including area code: (610) 940-5330
 
Date of fiscal year end: December 31
Date of reporting period: March 31, 2008
 



 
Item 1. Schedule of Investments.

 
Cheswold Lane International High Dividend Fund
 
 
Schedule of Investments
 
 
March 31, 2008
 
 
(Unaudited)
 
                 
Number of
           
Shares
     
Value
                 
     
COMMON STOCKS
98.6%
       
                 
     
CONSUMER DISCRETIONARY
6.7%
       
 
8,500
 
Compagnie Financiere Richemont S.A.
   
$
476,740
 
 
18,500
 
Honda Motor Co., Ltd.
     
528,015
 
 
14,000
 
Nissan Motor Co., Ltd.
     
115,730
 
 
13,500
 
Toyota Motor Corp.
     
673,104
 
 
10,000
 
Vivendi
     
390,742
 
 
30,000
 
The Yokohama Rubber Co., Ltd.
     
143,559
 
           
 
2,327,890
 
     
CONSUMER STAPLES
12.8%
       
 
15,000
 
British American Tobacco PLC
     
562,943
 
 
21,600
 
Heineken NV
     
1,254,581
 
 
34,000
 
Henkel KGaA
     
1,442,857
 
 
36,000
 
Unilever NV
     
1,208,885
 
           
 
4,469,266
 
     
ENERGY
18.0%
       
 
111,000
 
BP PLC
     
1,127,910
 
 
8,000
 
ENI SpA
     
272,809
 
 
25,000
 
Neste Oil OYJ
     
873,842
 
 
25,000
 
Saipem SpA
     
1,011,983
 
 
35,500
 
StatoilHydro ASA
     
1,063,820
 
 
8,000
 
Technip S.A.
     
623,040
 
 
17,500
 
Total S.A.
     
1,299,632
 
           
 
6,273,036
 
     
FINANCIALS
19.6%
       
 
23,790
 
Aegon NV
     
350,046
 
 
5,500
 
AXA S.A.
     
199,626
 
 
48,000
 
Banco Bilbao Vizcaya Argentaria S.A.
     
1,057,135
 
 
50,000
 
Bank of Ireland
     
743,594
 
 
120,000
 
Barclays PLC
     
1,078,850
 
 
5,500
 
BNP Paribas
     
554,767
 
 
17,500
 
Commerzbank AG
     
547,039
 
 
3,200
 
Credit Suisse Group
     
162,884
 
 
1,500
 
Deutsche Bank AG
     
169,795
 
 
34,000
 
Irish Life & Permanent PLC
     
664,530
 
 
105,000
 
Old Mutual PLC
     
230,268
 
 
125,000
 
UniCredit SpA
     
836,741
 
 
12,500
 
Westpac Banking Corp.
     
271,314
 
           
 
6,866,589
 
 
See accompanying notes to schedule of investments.
2

 
 
Cheswold Lane International High Dividend Fund
 
 
Schedule of Investments (continued)
 
 
March 31, 2008
 
 
(Unaudited)
 
                 
Number of
           
Shares
     
Value
                 
     
HEALTH CARE
3.0%
       
 
12,500
 
Fresenius Medical Care AG & Co., KGaA
   
$
628,542
 
 
8,500
 
Takeda Pharmaceutical Co., Ltd.
     
425,512
 
           
 
1,054,054
 
     
INDUSTRIALS
2.8%
       
 
8,500
 
Alfa Laval AB
     
516,422
 
 
22,500
 
Orkla ASA
     
284,986
 
 
1,500
 
Schneider Electric S.A.
     
194,092
 
           
 
995,500
 
     
INFORMATION TECHNOLOGY
7.7%
       
 
14,000
 
Canon, Inc.
     
644,663
 
 
14,500
 
Hoya Corp.
     
340,389
 
 
43,250
 
Nokia OYJ
     
1,368,355
 
 
5,500
 
Tokyo Electron, Ltd.
     
334,370
 
           
 
2,687,777
 
     
MATERIALS
7.1%
       
 
13,000
 
BHP Billiton Ltd.
     
425,449
 
 
13,000
 
JSR Corp.
     
294,091
 
 
10,000
 
Nitto Denko Corp.
     
422,352
 
 
7,000
 
Shin-Etsu Chemical Co., Ltd.
     
361,657
 
 
65,000
 
Sumitomo Chemical Co., Ltd.
     
416,031
 
 
8,000
 
Voestalpine AG
     
555,722
 
           
 
2,475,302
 
     
TELECOMMUNICATIONS
13.4%
       
 
41,000
 
France Telecom S.A.
     
1,378,728
 
 
235,000
 
Telecom Italia SpA
     
491,585
 
 
30,000
 
Telefonica S.A.
     
862,001
 
 
41,000
 
Telenor ASA
     
785,001
 
 
385,000
 
Vodafone Group PLC
     
1,153,006
 
           
 
4,670,321
 
     
UTILITIES
7.5%
       
 
6,400
 
E.ON AG
     
1,184,800
 
 
11,750
 
RWE AG
     
1,444,333
 
           
 
2,629,133
 
                 
 
 
 
TOTAL COMMON STOCKS (Cost $33,586,927)
   
 
34,448,868
 
                 
     
TOTAL INVESTMENTS (Cost $33,586,927)
98.6%
   
34,448,868
 
 
 
             
                 
     
Other Assets Less Liabilities
1.4%
   
473,649
 
           
 
 
 
     
NET ASSETS
100.0%
 
$
34,922,517
 
 
See accompanying notes to schedule of investments.
3


Cheswold Lane International High Dividend Fund
Schedule of Investments (Continued)
March 31, 2008
(Unaudited)
 
Investments by Country
 
(As a Percentage of Long-Term Investments)
 
       
Australia
   
2.0
%
Austria
   
1.6
 
Finland
   
6.5
 
France
   
13.5
 
Germany
   
15.7
 
Ireland
   
4.1
 
Italy
   
7.6
 
Japan
   
13.6
 
Netherlands
   
8.2
 
Norway
   
6.2
 
Spain
   
5.6
 
Sweden
   
1.5
 
Switzerland
   
1.9
 
United Kingdom
   
12.0
 
Total
   
100.0
%
 
See accompanying notes to schedule of investments.
4


Cheswold Lane International High Dividend Fund
Schedule of Investments
March 31, 2008
(Unaudited)

 
FOREIGN CURRENCY CONTRACTS OPEN AT MARCH 31, 2008
 
   
Contract Amount
     
Currency
 
Unrealized
 
Settlement Date
 
Pay
 
 
 
Receive
 
 
 
Value
 
Gain / (Loss)
 
                           
April 1, 2008
   
33,256,041
   
JPY
 
$
332,644
   
USD
 
$
333,628
   
($984
)
April 2, 2008
   
669,418
   
NOK
   
130,805
   
USD
   
131,456
   
(651
)
                                       
Total
                                 
($1,635
)
 
See accompanying notes to schedule of investments.
5


Cheswold Lane International High Dividend Fund
NOTES TO SCHEDULE OF INVESTMENTS
March 31, 2008
(Unaudited)
 
Note 1. Federal Income Tax Information
 
At March 31, 2008, gross unrealized appreciation and depreciation of investments and foreign currency owned by the Fund, based on cost for federal income tax purposes, were as follows:
 
Aggregate cost of investments
 
$
33,586,927
 
Gross unrealized appreciation
   
3,532,234
 
Gross unrealized depreciation
   
(2,661,805
)
Net unrealized appreciation on investments
and foreign currency translations
 
$
870,429
 
 
The difference between cost amounts for financial statement and federal income tax purposes is due primarily to timing differences in recognizing certain gains and losses in security transactions.
 
 
Note 2. Financial Accounting Standards No. 157 - In September 2006, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements” (“FAS 157”) effective for fiscal years beginning after November 15, 2007. FAS 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. The Fund adopted FAS 157 as of January 1, 2008. Under FAS 157, various inputs are used in determining the value of the Fund’s investments. These inputs are summarized into three broad levels and described below:
 
 
§
Level 1 - quoted prices in active markets for identical securities
 
§
Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, and evaluated quotations obtained from pricing services.)
 
§
Level 3 - significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments.)

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities. The following is a summary of the inputs used, as of March 31, 2008, in valuing the Fund’s assets:

Valuation Inputs
Investment in Securities
Other Financial Instruments*
Level 1 - Quoted Prices
$34,448,868
-
Level 2 - Other Significant Observable Inputs
-
($1,635)
Level 3 - Significant Unobservable Inputs
-
-
Total
$34,448,868
($1,635)
 
* Other financial instruments include futures, forwards and swap contracts, which are valued at unrealized appreciation/depreciation on the investment.
 
6


 
Item 2. Controls and Procedures.

(a)
The registrant’s principal executive officer and principal financial officer have reviewed the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) as of a date within 90 days of the filing of this report and have concluded that the disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized, reported and made known to them by others within the registrant and by the registrant’s service providers.

(b)
There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the registrant’s last fiscal quarter that materially affected, or were reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3. Exhibits.

Certifications, as required by Rule 30a-2(a) under the 1940 Act, for the Principal Executive Officer and Principal Financial Officer are filed herewith.

7


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant) Cheswold Lane Funds

By: /s/ Eric F. Scharpf
 
Eric F. Scharpf, President and Chief Executive Officer
(Principal Executive Officer)
Date: May 27, 2008

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By: /s/ Eric F. Scharpf

Eric F. Scharpf, President and Chief Executive Officer
(Principal Executive Officer)
Date: May 27, 2008
 
By: /s/ Matthew H. Taylor 
Matthew H. Taylor, Executive Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
Date: May 27, 2008

8

EX-99.CERT 2 v114267_ex99-cert.htm

Ex-99.CERT
Cheswold Lane Funds
Item 3 to Form N-Q


CERTIFICATIONS


I, Eric F. Scharpf, certify that:

1. I have reviewed this report on Form N-Q of Cheswold Lane Funds;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


 
 

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 27, 2008
/s/ Eric F. Scharpf

Eric F. Scharpf
President and Chief Executive Officer
(Principal Executive Officer)

 
 

 

Ex-99.CERT
Cheswold Lane Funds
Item 3 to Form N-Q


CERTIFICATIONS

 
I, Matthew H. Taylor, certify that:

1. I have reviewed this report on Form N-Q of Cheswold Lane Funds;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


 
 

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 27, 2008
/s/ Matthew H. Taylor

Matthew H. Taylor
Executive Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)

 
 

 


-----END PRIVACY-ENHANCED MESSAGE-----